seen from Malaysia
seen from China
seen from Malaysia
seen from United States
seen from United States
seen from United States
seen from United States
seen from United States
seen from Russia
seen from Australia
seen from Singapore
seen from Russia
seen from United States
seen from Japan
seen from United States
seen from United States
seen from United States
seen from United States
seen from United Kingdom
seen from United States
Cipla sees weight-loss drugs as the biggest opportunity in the Indian market
Drugmaker Cipla Ltd anticipates GLP-1 drugs, used for treating type-2 diabetes and obesity, to be a definite new therapy in the Indian market, and is exploring a wider foray, said chief executive Umang Vohra. “The Indian market is particularly important to us, where we’re looking at the whole GLP-1 category and not just Semaglutide alone,” Vohra told reporters in a media interaction on Friday…
Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.
Free to watch • No registration required • HD streaming
Get ABBOTINDIA live BSE/NSE share price & movement, market cap, fundamental & technical analysis, company profile, financial report, shareho
